List of qualifications to be added here
Biography information to be added here
MBChB Year 5, MBChB Year 4, MBChB Year 3, MBChB Year 2, MBChB Year 1, BMedSci 3, BMedSci 2, BMedSci 1, Clinical Oncology MSc/PG Dip
Professor Moss makes substantial contributions to teaching at many levels, both within the University of Birmingham and beyond. He is currently Programme Director of the Intercalated Batchelor in Medical Sciences (Clinical Sciences) which offers medical students the opportunity to undertake an 8 month research project during their undergraduate degree. The course also has a dedicated programme of lecturers within the 6 themes of haematology, infection, histopathology, cancer studies, immunology and metabolic medicine.
Postgraduate supervision information to be added here
Cancer Cell Biology, Clinical Trials, Tumour Immunology and Immune/Gene Therapy, Viral Oncology
Professor Moss’s research is focussed around the application of translational immunological research in the study of human disease. His current research group includes clinical and non-clinical research scientists working on a range of different projects:
The role of cytomegalovirus infection in human health and disease
Mechanisms of graft-versus-leukaemia following stem cell transplantation
The immune response against cancers
The Immunology of pregnancy
The role of DARC mutation in the development of ethnic neutropenia
Clinical Activity/NHS Affiliation
Professor Moss is an honorary consultant at the University Hospitals Birmingham NHS Foundation Trust. His primary interests are in haemato-oncology and general haematology and he is the Clinical Service Lead for chronic lymphocytic leukaemia.
MD Morgan, CJ Day, KP Piper, N Khan, L Harper, P Moss, COS Savage (2010) Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells.
G Chakupurakal, D Onion, M Cobbold, V Mautner, P Moss (2009) Adenovirus vector-specific T cells demonstrate a unique memory phenotype with high proliferative potential and coexpression of CCR5 and integrin alpha4beta7
S Nicholls, KP Piper, F Mohammed, TR Dafforn, S Tenzer, M Salim, P Mahendra, CF Craddock, P van Endert, H Schild, M Cobbold, VH Engelhard, P Moss, BE Willcox (2009) Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition
Proceedings of the National Academy of Sciences of the United States of America 106 3889-94
S Chidrawar, N Khan, W Wei, A McLarnon, N Smith, L Nayak, P Moss (2009) Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals.
Clinical and experimental immunology 155 423-32
HM McGettrick, K Hunter, P Moss, CD Buckley, GE Rainger, GB Nash (2009) Direct observations of the kinetics of migrating T cells suggest active retention by endothelial cells with continual bidirectional migration
Journal of Leukocyte Biology 85 98-107